ITC Testimony
Request for Comments on USPTO Initiatives to Ensure the Robustness and Reliability of Patent Rights (USPTO Docket No. PTO-P-2022-0025)
Public Comment Joint USPTO-FDA Collaboration Initiatives; Notice of Public Listening Session
Supplemental Comments on the Joint USPTO-FDA Collaboration Initiatives Listening Session
Letter to Senator Tillis
ITC Adalimumab Submission
PTO Director for America: A letter to President Joe Biden
Statement for Hearing on The Patient Perspective: The Devastating Impacts of Skyrocketing Drug Prices on American Families
FTC Submission: Competition and Consumer Protection in the 21st Century
I-MAK Submission to FTC on the Role of Intellectual Property
1
2